Advertisement
Screener

CLIMB BIO, INC. (CLYM) ROA

CLIMB BIO, INC. (CLYM) ROA

  • 2026-06-30: ROA -23.40%.
  • 2026-03-31: ROA -34.65%.
  • 2025-12-31: ROA -35.68%.
  • 2025-09-30: ROA -27.84%.

Complete source-backed roa history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-23.40%
2026-03-31-34.65%
2025-12-31-35.68%
2025-09-30-27.84%
2025-06-30-24.30%
2025-03-31-46.32%
2024-12-31-34.02%
2024-09-30-31.11%
2024-06-30-28.40%
2024-03-31-13.29%
2023-12-31-31.79%
2023-09-30-34.81%
2023-06-30-38.66%
2023-03-31-44.50%
2022-12-31-33.52%
2022-09-30-34.10%
2022-06-30-31.95%
2022-03-31-25.91%
2021-12-31-27.41%
2021-09-30-28.42%
2021-06-30-41.29%
2020-12-31-83.91%

Annual ROA

DateROA
2025-12-31-35.68%
2024-12-31-34.02%
2023-12-31-31.79%
2022-12-31-33.52%
2021-12-31-27.41%
2020-12-31-83.91%

Similar stocks

Stock NameCountryMarket CapPE Ratio
IRONWOOD PHARMACEUTICALS INC (IRWD)United States$0.694B5.37
ZEVRA THERAPEUTICS, INC. (ZVRA)United States$0.668B14.61
Nuvectis Pharma, Inc. (NVCT)United States$0.705B-17.53
Verastem, Inc. (VSTM)United States$0.706B-1.71
BlossomHill Therapeutics, Inc. (BLSM)United States$0.647B
Shattuck Labs, Inc. (STTK)United States$0.634B-13.30
COLLEGIUM PHARMACEUTICAL, INC (COLL)United States$0.737B24.57
Neurogene Inc. (NGNE)$0.625B-4.46
Faeth Therapeutics, Inc. (FTH)United States$0.750B
IMPACT BIOMEDICAL INC. (IBO)United States$0.611B66.47